In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback